Rosiglitazone For Type 2 Diabetes Does Not Increase Risk Of Cardiovascular Disease Or Death But Increases Heart Failure And Fractures In Women

Using rosiglitazone (Avandia) in combination with standard diabetes treatments (metformin or a sulfonylurea) to lower blood glucose in type 2 diabetics does not increase the risk of cardiovascular disease or death. However, the study confirms that using rosiglitazone more than doubles the risks of heart failure, and also increases the risk of fractures, mainly in women. The findings of the RECORD study are published in an Article Online First and in an upcoming edition of

Food Retailers Need To Prove Commitment To Health, Says British Heart Foundation

In response to the report ‘A Commitment to Health’ published by the British Retail Consortium Alex Callaghan, Policy Officer at the British Heart Foundation (BHF) said:

“Whilst food retailers have made some efforts to help consumers make healthy choices, on the key issue of food labelling, they are still resisting change.

“If retailers want to prove their commitment to people’s health they should bring in food labelling model which combines traffic light colours, GDAs and the words high, medium and low.

Food Retailers Need To Prove Commitment To Health, Says British Heart Foundation

In response to the report ‘A Commitment to Health’ published by the British Retail Consortium Alex Callaghan, Policy Officer at the British Heart Foundation (BHF) said:

“Whilst food retailers have made some efforts to help consumers make healthy choices, on the key issue of food labelling, they are still resisting change.

“If retailers want to prove their commitment to people’s health they should bring in food labelling model which combines traffic light colours, GDAs and the words high, medium and low.

World Heart Federation Warns That Burden Of Tobacco Epidemic Continues To Worsen Societies And Economies – 6 M People Will Die And $500 Billion Lost

G-20 leaders pledged to provide the International Monetary Fund with $500 billion to help struggling economies, sparking global controversy. Yet startling research shows that the combined costs of tobacco-related death and related productivity losses, healthcare expenditures, employee absenteeism, and widespread environmental harm are responsible for draining the same amount – $500 billion – from the global economy each year and it receives much less attention than it deserves.

Laugh A Little To Help Protect Heart, Lower Blood Pressure

Laughter is not only an effective stress-reliever, but can be heart-healthy, according to research presented at the American College of Sports Medicine’s 56th Annual Meeting in Seattle. Two separate studies examined the role of a good laugh as it relates to health.

One of the studies took an inverted approach to previous research on the harmful cardiovascular tolls of stress and negative mood. A small group of healthy adults were instructed to watch either a comedy or documentary film, and were monitored for carotid artery activity during the films.

Cytori Completes Enrollment In First Adipose Stem & Regenerative Cell Therapy Trial For Chronic Heart Disease

Cytori (NASDAQ:CYTX) completed enrollment in the first study to investigate adipose derived stem and regenerative cells in chronic heart disease. The trial, which has been named the PRECISE study, was carried out at leading cardiology centers in Europe. It specifically enrolled patients suffering from an advanced form of chronic heart disease, known as chronic myocardial ischemia, for which there is no generally accepted treatment.

The trial enrolled 27 patients and was designed as a double-blind, randomized, placebo controlled, dose escalation study. It is unique in that the patients’ own cells were extracted from adipose tissue and processed for delivery at the point of care using Cytori’s Celution System. The cells were then injected back into the patients using the NOGA XP System (Biologics Delivery Systems, Cordis Corp., a Johnson and Johnson company), which identifies and guides cells to damaged regions of the heart.

New Strategies For Cell Therapy To Regenerate Damaged Heart

Research undertaken at the Center for Applied Medical Research (CIMA) and the University Hospital of Navarra has shown that, in animal models, stem cells derived from bone marrow and adipose tissue enhance heart function after a cardiac attack. In concrete, bone marrow cells act on the damaged tissue, while fatty cells have the ability to transform themselves into both blood vessels and cardiac cells. The results obtained with rats are maintained over a long time period, explained biochemist Mr Manuel Mazo, principal researcher.

Reducing Heart Attack Risk In Diabetes

People with diabetes who maintain intensive, low blood sugar levels are significantly less likely to suffer heart attacks and coronary heart disease, new research published in The Lancet has shown.

By undertaking a meta-analysis which pooled information from five large trials, researchers at the University of Cambridge were for the first time able to provide reliable evidence linking intensive blood sugar level (or glucose) control with fewer heart attacks.

UPMC Cardiovascular Institute Recruiting For Severe Coronary Heart Disease Study

The UPMC Cardiovascular Institute currently is enrolling participants for a Phase 2 clinical trial to examine whether administering a naturally occurring protein improves blood supply to the cardiac muscle in patients with severe coronary artery disease.

The study, known as Angiogenesis for the Treatment of Coronary Heart Disease (ACORD), is a randomized, double-blind, placebo-controlled trial that compares the use of a protein at three dose levels with a placebo. The therapy is delivered to the heart muscle by threading a catheter through a small incision in the upper leg.

Study Finds ICDs Extend The Lives Of Heart Attack Survivors By An Entire Year

A landmark follow-up study found that heart attack survivors who receive implanted cardioverter defribillators (ICDs) live longer the longer they have them, according to the results of late-breaking clinical trail presented at the annual Scientific Sessions of the Heart Rhythm Society.

ICDs are devices designed to correct arrhythmias, electrical malfunctions that throw the heart out of rhythm and cause many of the sudden cardiac deaths each year in the United States. Most fatal arrhythmias in the aging are caused by scar tissue left behind by heart attacks that interferes with the heart’s electrical system.